Paclitaxel Protein-Bound Particles For Injectable Suspension (albumin-Bound) 68001-0651-37
Generic: Paclitaxel
- Manufacturer
- Bluepoint Laboratories
- Dosage Form
- Injection, Powder, Lyophilized, For Suspension
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 18, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA216355
Need to source Paclitaxel Protein-Bound Particles For Injectable Suspension (albumin-Bound)? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Paclitaxel | 100 mg/20mL |
Drug Class
Microtubule Inhibitor [EPC]Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]
Selected Package
68001-0651-37Selected1 VIAL, SINGLE-USE in 1 CARTON (68001-651-37) / 20 mL in 1 VIAL, SINGLE-USE